Patents by Inventor Sebastian LETSCHERT

Sebastian LETSCHERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD19CART CELLS ELIMINATE MYELOMA CELLS THAT EXPRESS VERY LOW LEVELS OF CD19
    Publication number: 20200209240
    Abstract: The invention generally relates to immunotherapy with chimeric antigen receptor (CAR}- engineered T-cells. In particular, the invention relates immunotherapy with chimeric antigen receptor (CAR)-engineered T-cells to target sub-populations of cancer cells that are characterized by low expression of a cancer cell surface antigen, more particular the invention relates to immunotherapy with chimeric antigen receptor (CAR)-engineered T-cells targeting CD19 (CD19CART) in multiple myeloma, a clonal proliferation of plasma cells.
    Type: Application
    Filed: November 20, 2018
    Publication date: July 2, 2020
    Inventors: Hermann EINSELE, Michael HUDECEK, Sebastian LETSCHERT, Thomas NERRETER, Markus SAUER